How genomics is contributing to the fight against artemisinin-resistant malaria parasites

Pedro Cravo, Hamilton Napolitano, Richard Culleton

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

Plasmodium falciparum, the malignant malaria parasite, has developed resistance to artemisinin, the most important and widely used antimalarial drug at present. Currently confined to Southeast Asia, the spread of resistant parasites to Africa would constitute a public health catastrophe. In this review we highlight the recent contributions of genomics to our understanding how the parasite develops resistance to artemisinin and its derivatives, and how resistant parasites may be monitored and tracked in real-time, using molecular approaches.

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalActa Tropica
Volume148
DOIs
Publication statusPublished - Aug 2015

Keywords

  • Africa
  • Animals
  • Antimalarials
  • Artemisinins
  • Asia, Southeastern
  • Drug Resistance
  • Genomics
  • Humans
  • Malaria, Falciparum
  • Plasmodium falciparum
  • Journal Article
  • Review

UN Sustainable Development Goals (SDGs)

  • SDG 3 - Good Health and Well-Being

Fingerprint Dive into the research topics of 'How genomics is contributing to the fight against artemisinin-resistant malaria parasites'. Together they form a unique fingerprint.

Cite this